Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,655 | 47,810 | 8,350 | N/A | 10,312 |
| Marketable Securities | 113,644 | 93,070 | 19,449 | N/A | 0 |
| Other current assets | 1,807 | 320 | 226 | 0 | 71 |
| TOTAL | $124,106 | $141,200 | $28,025 | $N/A | $10,383 |
| Non-Current Assets | |||||
| PPE Net | 9,034 | 3,201 | 1,946 | N/A | 1,882 |
| Other Non-Current Assets | 743 | 385 | 228 | 0 | 233 |
| TOTAL | $9,777 | $3,586 | $2,174 | $N/A | $2,115 |
| Total Assets | $133,883 | $144,786 | $30,199 | $N/A | $12,498 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 947 | 1,233 | 152 | 0 | 342 |
| Accrued Expenses | 3,927 | 1,407 | 668 | N/A | 471 |
| Other current liabilities | 1,867 | 1,867 | 1,283 | N/A | 667 |
| TOTAL | $7,794 | $5,018 | $2,429 | $N/A | $1,808 |
| Non-Current Liabilities | |||||
| TOTAL | $2,641 | $1,054 | $503 | $N/A | $481 |
| Total Liabilities | $10,435 | $6,073 | $2,932 | $N/A | $2,289 |
| Shareholders' Equity | |||||
| Common Shares | 19 | 18 | 2 | N/A | 2 |
| Retained earnings | -45,669 | -22,634 | -12,915 | N/A | -9,754 |
| Other shareholders' equity | -2,649 | -2,801 | 37,465 | 0 | 19,913 |
| TOTAL | $123,448 | $138,714 | $27,267 | $N/A | $10,209 |
| Total Liabilities And Equity | $133,883 | $144,787 | $30,199 | $0 | $12,498 |